We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


CLC bio Delivers Specialized Immunoinformatics Solution to Symphogen

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "CLC bio Delivers Specialized Immunoinformatics Solution to Symphogen"

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Read time:
CLC bio has just completed a specialized immunoinformatics solution that is fully customized to fit into Symphogen’s proprietary Symplex™ technology for high throughput identification of antibodies with diversity and specificity customized to a particular therapeutic application.

CLC bio has developed a CLC Main Workbench plug-in, which is designed to optimize the end-to-end workflow and analysis pipeline when working with the large number of antibodies retrieved during the Symplex™ process.

“When investigating the diversity and complexity of disease-relevant antibody repertories from human donors, speed and quality are essential. Thus, the faster we can go through our initial bioinformatics workflow and identify a diverse panel of complementary antibodies of interest, the earlier we can compose the optimal recombinant polyclonal antibody (rpAb) drug lead candidate to advance into development - this is of course of the utmost importance to us” says Director of Antibody Discovery at Symphogen, Dr. Allan Jensen, PhD.

He continues, “CLC bio has fully integrated the workflow by automating all the steps in the downstream bioinformatics analysis process. Not only has this accelerated the research process tremendously by eliminating tedious and complicated manual procedures but it also removes the overhead of keeping third party software running and updated - and in turn it provides a high quality and robust workflow.”

Director of Consulting Services at CLC bio, Dr. Jannick D. Bendtsen, continues, “Where Symplex™ is a cutting-edge concept for testing on humans and in the lab, Symphogen’s new special plug-in is designed to analyze the sequencing data coming from all these research projects, and integrate them nicely into an end-to-end workflow. We are proud to deliver this intricate solution to Symphogen, which stresses the flexibility and stability that our overall bioinformatics platform provides, and we look forward to seeing Symphogen’s projects coming faster through their development phases.”